# Treatment of Diabetes in Patients With Systolic Heart Failure

> **NCT02920918** · PHASE4 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 36 (actual)

## Conditions studied

- Heart Failure, Systolic
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Canagliflozin
- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT02920918
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02920918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02920918, "Treatment of Diabetes in Patients With Systolic Heart Failure". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02920918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*